Achmea Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-202,584
Closed -$57.2M 135
2025
Q3
$57.2M Buy
202,584
+870
+0.4% +$252K 0.71% 25
2025
Q2
$56.3M Buy
201,714
+51,293
+34% +$14.5M 0.73% 26
2025
Q1
$46.9M Buy
150,421
+139,409
+1,266% +$41.2M 0.68% 31
2024
Q4
$2.87M Sell
11,012
-7,705
-41% -$2.29M 0.05% 263
2024
Q3
$6.03M Sell
18,717
-10,569
-36% -$3.46M 0.1% 209
2024
Q2
$9.15M Sell
29,286
-17,425
-37% -$5.12M 0.16% 155
2024
Q1
$13.3M Buy
46,711
+26,939
+136% +$7.88M 0.25% 101
2023
Q4
$5.69M Buy
19,772
+1,967
+11% +$536K 0.12% 198
2023
Q3
$4.79M Sell
17,805
-73,736
-81% -$18.4M 0.1% 207
2023
Q2
$20.3M Sell
91,541
-875
-0.9% -$203K 0.43% 50
2023
Q1
$22.3M Buy
92,416
+7,613
+9% +$1.87M 0.65% 29
2022
Q4
$20.9M Buy
84,803
+24,247
+40% +$6.5M 0.7% 26
2022
Q3
$13.6M Sell
60,556
-345
-0.6% -$83.6K 0.48% 43
2022
Q2
$14.8M Sell
60,901
-219
-0.4% -$53.7K 0.48% 41
2022
Q1
$14.8M Buy
61,120
+5,924
+11% +$1.36M 0.39% 54
2021
Q4
$12.4M Buy
+55,196
New +$11.6M 0.59% 33
2020
Q1
Sell
-100,316
Closed -$24.2M 273
2019
Q4
$24.2M Sell
100,316
-6,968
-6% -$1.54M 0.93% 22
2019
Q3
$20.8M Sell
107,284
-15,063
-12% -$2.89M 0.82% 27
2019
Q2
$22.5M Sell
122,347
-5,979
-5% -$1.07M 0.86% 20
2019
Q1
$24.4M Buy
128,326
+2,003
+2% +$383K 1.02% 21
2018
Q4
$24.6M Buy
126,323
+785
+0.6% +$153K 1.14% 19
2018
Q3
$26M Buy
+125,538
New +$24.7M 0.99% 18
2017
Q4
Sell
-84,004
Closed -$15.7M 490
2017
Q3
$15.7M Buy
84,004
+2,558
+3% +$453K 0.89% 22
2017
Q2
$14M Sell
81,446
-21,960
-21% -$3.57M 0.84% 22
2017
Q1
$17M Buy
+103,406
New +$17.2M 0.8% 20

Other funds holding AMGN

Achmea Investment Management's AMGN Position: Q4 2025 in Review

Achmea Investment Management sold out of Amgen (AMGN) in Q4 2025, closing a stake of 202,584 shares — an estimated $57.2M sold.

Achmea Investment Management first reported a position in AMGN in Q1 2017 and held it in 25 quarters. The position peaked at $57.2M in Q3 2025. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Achmea Investment Management reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Achmea Investment Management sold 202,584 Amgen shares in Q4 2025, an estimated $57.2M.
  • Achmea Investment Management first reported a position in Amgen in Q1 2017 and held it in 25 quarters.
  • Achmea Investment Management's Amgen position peaked at $57.2M in Q3 2025.
  • 3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Achmea Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.